Anixa Biosciences Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | – | 100.0% | – | – | 100.0% | 100.0% | – | – | 100.0% | – | – | – | – | – | – | 100.0% | – | – | 100.0% | – | – | – | 100.0% | – | 100.0% | – | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 36.0% | – | – | 38.9% | – | – | 66.8% | 66.5% | – | – | 66.5% | – | – | – | – | – | – | 75.0% | – | – | 10.7% | – | – | – | 0.0% | – | 76.7% | – | 7.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 64.0% | – | – | 61.1% | – | – | 33.2% | 33.5% | – | – | 33.5% | – | – | – | – | – | – | 25.0% | – | – | 89.3% | – | – | – | 100.0% | – | 23.3% | – | 92.3% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 206.7% | – | – | 100.1% | – | – | 88.0% | 811.6% | – | – | 507.8% | – | – | – | – | – | – | 161.3% | – | – | 60.1% | – | – | – | 0.1% | – | 475.2% | – | 1,035.3% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 298.2% | – | – | 415.9% | – | – | 121.2% | 745.9% | – | – | 512.8% | – | – | – | – | – | – | 298.8% | – | – | 52.7% | – | – | – | 0.1% | – | 767.1% | – | 920.5% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 520.7% | – | – | 538.5% | – | – | 220.0% | 1,579.9% | – | – | 1,070.8% | – | – | – | – | – | – | 460.2% | – | – | 112.8% | – | – | – | 0.1% | – | 1,242.4% | – | 1,955.8% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -456.7% | – | – | -477.5% | – | – | -186.8% | -1,546.4% | – | – | -1,037.3% | – | – | – | – | – | – | -435.3% | – | – | -112.8% | – | – | – | -0.1% | – | -1,219.0% | – | -1,955.8% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 68.4% | – | – | 19.8% | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | 0.1% | – | – | 0.0% | – | – | – | 0.0% | – | 120.5% | – | 32.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -523.8% | – | – | -495.0% | – | – | -185.7% | -1,543.1% | – | – | -1,030.0% | – | – | – | – | – | – | -440.1% | – | – | -112.7% | – | – | – | -0.1% | – | -1,098.6% | – | -1,744.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 67.2% | – | – | 17.5% | – | – | -1.9% | -32.2% | – | – | -22.2% | – | – | – | – | – | – | -5.0% | – | – | -1.8% | – | – | – | 0.0% | – | -129.5% | – | -19.9% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -523.8% | – | – | -495.0% | – | – | -183.8% | -1,510.9% | – | – | -1,015.1% | – | – | – | – | – | – | -430.5% | – | – | -111.1% | – | – | – | -0.1% | – | -1,089.5% | – | -1,724.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -400.5% | – | – | -449.8% | – | – | -175.6% | -1,522.6% | – | – | -982.3% | – | – | – | – | – | – | -432.4% | – | – | -112.2% | – | – | – | -0.1% | – | -1,092.9% | – | -1,736.5% | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.